AUG 24, 2020 10:08 AM PDT

Injectable Drug Stops HIV From Entering Cells

WRITTEN BY: Tara Fernandes


Once in the body, HIV tracks down T cells that bear the CD4 receptor. It attaches to these immune cells, fusing itself with the T cell’s membrane before injecting its genetic material into the cell’s core. Next, the viral RNA is converted to a DNA format before the host cell’s machinery is hijacked to produce multiple new copies of the virus.

A collaborative effort led by University of Utah Health researchers has resulted in a new experimental treatment to block the first step in HIV infection: its entry into T cells. This new drug promises significant advantages over existing “cocktail” treatments including longer-lasting effects and fewer adverse side effects. The study was published in Proceedings of the National Academy of Sciences (PNAS).

Michael S. Kay, senior author and professor of biochemistry said, "This is an exciting new HIV therapeutic option for both prevention and treatment, with a unique mechanism of action compared to other approved drugs." 

HIV, the virus that causes AIDS, is among the biggest, toughest challenges in global health with approximately 38 million people worldwide with HIV/AIDS in 2019. The current standard of care involves combination antiretroviral therapy, or cART, a cocktail of drugs that improves the quality of life for the patients that take it. The downsides of this form of treatment, however, are that it’s expensive, needs to be taken daily, has serious side effects, and frequent HIV mutations mean the possibility of drug resistance.

The newly-developed drug, called CPT31 was inspired by a natural peptide that fuses to a pocket in HIV’s fusion machinery — a region not prone to mutation. CPT31 is a D-peptide, a type of protein that, due to its molecular conformation, makes it optimal for use in long-acting injectable drug formulations. This would make taking a daily regimen of pills a thing of the past for HIV patients.

"In addition to their durability in the body, D-peptides are largely ignored by the immune system, preventing immune reactions that are a side effect often seen with traditional peptide and protein drugs," said Brett Welch, a co-author on the study.

The scientists see the potential for CPT31 being not only a therapeutic for HIV but also as a prophylactic, or preventative, therapy.

"We think this drug could be used by itself to prevent HIV infection because initial HIV exposure typically involves a relatively small amount of virus," said Kay.

 

Sources: PNAS, Medical Xpress.


 

About the Author
PhD
Interested in health technology and innovation.
You May Also Like
MAY 08, 2022
Technology
Detecting Cytokine Storm Through Sweat
MAY 08, 2022
Detecting Cytokine Storm Through Sweat
A cytokine storm is a severe immune system reaction where the body is flooded with cells and molecules (called cytokines ...
JUN 10, 2022
Immunology
Is Autoimmunity Related to Schizophrenia?
JUN 10, 2022
Is Autoimmunity Related to Schizophrenia?
Schizophrenia is estimated to impact around 24 million people, which is about 1 in 300 people worldwide. This poorly und ...
JUN 16, 2022
Coronavirus
Long Covid and Sleep Disturbances
JUN 16, 2022
Long Covid and Sleep Disturbances
The Cleveland Clinic presented research on long COVID’s effects on sleep during 2022 Sleep Week (the annual meetin ...
JUN 21, 2022
Immunology
Can Allergy Symptoms be Relieved by Treating Micronutrition Deficiencies?
JUN 21, 2022
Can Allergy Symptoms be Relieved by Treating Micronutrition Deficiencies?
New research has indicated that deficiencies in micronutrients can promote inflammation, and make the immune system more ...
JUL 21, 2022
Immunology
For the First Time, Microscopy Catches Antibodies Attacking a Receptor
JUL 21, 2022
For the First Time, Microscopy Catches Antibodies Attacking a Receptor
Using cryo-electron microscopy, researchers captured images of a molecule called an autoantibody as it attached to a rec ...
AUG 02, 2022
Neuroscience
Could Common Viruses be Triggering Alzheimer's?
AUG 02, 2022
Could Common Viruses be Triggering Alzheimer's?
Recent allegations of research misconduct have called years of Alzheimer's research into question. The controversy surro ...
Loading Comments...